← Eichor
Study identifier: NCT05777330 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes

Condition: Type1 Diabetes Mellitus  ·  Sponsor: Universitair Ziekenhuis Brussel

PhaseNA
Planned participants75
Who can joinAll sexes, 5 Years to 39 Years
Healthy volunteersNo

About this study

The goal of this longitudinal clinical trial is to measure variability of interstitial glucose levels with a user-friendly real-time continuous glucose monitoring (CGM) technology at regular intervals in normo- and dysglycemic multiple autoantibody-positive individuals (age 5-39 years), in comparison with single autoantibody-positive individuals in the same age range. Participants will asked to undergo repeated oral glucose tolerance tests (OGTTs) (age 5-39 years) and hyperglycemic clamp tests (age 12-39 years) in parallel for a period of at least 2-3 years. In case of confirmed dysglycemia, we propose to perform CGM and OGTT every 3 months. The main questions the study aims to answer are: 1. Do the amplitude and time trends of CGM-derived glycemic variability indices and OGTT- and clamp-derived variables differ between the intermediate, high and very high risk groups? 2. Can (changes in) CGM-derived glycemic variability indices predict/detect dysglycemia in initially normoglycemic (single or multiple autoantibody-positive) individuals with the same diagnostic efficiency as OGTT- or clamp-derived variables? 3. Can (changes in) CGM-derived glycemic variability indices predict clinical onset in (stage 1 or 2) multiple autoantibody-positive individuals with the same diagnostic efficiency as OGTT- or clamp-derived variables? 4. Can correlating (changes in) CGM-derived indices with (changes in) OGTT- and clamp-derived variables help to better understand the sequence of events le…

This description comes directly from the study's public registry record.

Talk to the study team

Belgian Diabetes Registry  ·  02 477 45 46  ·  contact@bdronline.be

Always discuss trial participation with your own doctor first.

Locations (6)

Clinique CHC MontLégiaLiège, Liège, BelgiumRecruiting
A.Z. Sint-Jan BruggeBruges, West-Vlaanderen, BelgiumRecruiting
Universitair Ziekenhuis AntwerpenAntwerp, BelgiumRecruiting
Universitair Ziekenhuis GentGhent, BelgiumRecruiting
Universitair Ziekenhuis BrusselJette, BelgiumRecruiting
Universitair Ziekenhuis LeuvenLeuven, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05777330